KADCYLA Reviews

Average Rating: 4.2 (4 Ratings)

Filter Results

Compare KADCYLA with similar:

 Type: Biological Drug
  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR KADCYLACOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 4  Metastatic breast cancer Tired 3 to 4 days after F 66 2 days
Drip 1X M
4/18/2021
 4  HER2+ Breast Cancer Maint Drug Very tired the next 4-5 days after treatment F 37 16 times
1X M
11/30/2020
 4  Metastatic breast cancer Tired nausea muscle pain Looking to see if anyone has symptoms months after taking F 50 1 years
1X D
10/17/2020
Email
 5  Breast cancer Nausea the following day after administration F 36 1 years
1/21/2015
  

KADCYLA  (ADO-TRASTUZUMAB EMTANSINE):  Ado-trastuzumab emtansine is used alone to treat certain types of breast cancer. This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein. This medication is called a monoclonal antibody and microtubule inhibitor conjugate. Ado-trastuzumab emtansine works by attaching to the HER2 cancer cells and blocking them from dividing and growing. It may also destroy the cancer cells or signal the body (immune system) to destroy the cancer cells.   (Sources: U.S. Centers for Medicare Services, FDA)

BACK TO TOP